The Quebec Summit on Multiple Sclerosis will be held at:
1228 Nobel Street
Boucherville, Quebec J4B 5H1
Tel.: 450 655-9966
Toll-free: 1 877 655-9966
There is no registration fee. The Quebec Summit on Multiple Sclerosis is offered free of charge, thanks to our generous sponsors.
The Hôtel Mortagne is accessible. The presentations will be given in the conference centre on the ground floor. Wheelchair-accessible toilets are available.
Some of the speakers are francophones and others are anglophones. A simultaneous interpretation service will be available for all presentations. When you register, please indicate whether you need this service. Please note that you’ll be able to ask questions in French or English during the question period.
Lunch boxes will be provided for all participants. If you have allergies or food intolerances or if you are vegetarian, please let us know in advance.
A limited number of rooms have been reserved (including 13 adapted rooms) at the rate of $159 plus taxes. You have until March 6, 2017, to benefit from this rate. To reserve, please call the Hôtel Mortagne directly, at 450 655-9966 or 1 877 655-9966 (toll-free) or e-mail firstname.lastname@example.org, and mention the code “15911 – Multiple Sclerosis Society of Canada.”
From Highway 20 East
Take exit 93 from Highway 20 East.
Turn right on Nobel.
The hotel is on your left.
From Highway 20 West
Take exit 92 from Highway 20 West.
Turn left on Boulevard de Mortagne and cross over the highway.
Then turn left on Volta and left again on Nobel. The hotel is on your right.
Free parking is available outside the hotel.
You can get to the Hôtel Mortagne by the Réseau de transport de Longueuil’s 123 bus line, starting at Longueuil metro station (there’s a stop opposite the Hôtel Mortagne). It takes about 40 minutes to get there from the metro.
The deadline for registering for the event is March 31, 2017, conditional to the available space in the conference room. Register sooner in order to insure a seat.
Did you know?
To date, the MS Society has invested more than $150 million in research.